Medrus Pharma Consulting Limited
11240370
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 04/03/2026
Due 18/03/2027
Industry
Officers
director · Since 07/03/2018
PHARMACEUTICAL EXECUTIVE
BRITISH · ENGLAND · Age 66
Also on 2 other boards
Persons with Significant Control
Mrs Delyth Eluned Jones
British · United Kingdom · Age 67
Westminster House, 10 Westminster Road, Macclesfield, SK10 1BX
Notified 07/03/2018
Dr Andrew John Jones
British · England · Age 66
Westminster House, 10 Westminster Road, Macclesfield, SK10 1BX
Notified 07/03/2018
CompanyRankvs 8414+ SIC 71122 peers57
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£110
Balance sheet strength
Cash
£15k
Cash in the bank
Net Current Assets
£11k
Working capital
Current Assets
£15k
Current Liabilities
£5k
Fixed Assets
£1k
Debtors
£110
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 3.38 |
| 2024 | 11.34 |
| 2023 | 11.87 |
| 2022 | 22.85 |
| 2021 | 14.69 |
| 2020 | 10.79 |
| 2019 | 4.35 |
Derived from filed accounts. Not audited figures.